10663549falseOTHER HUMAN HEALTH ACTIVITIES2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/cd:Director12024-04-012025-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2025-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2024-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-04-012025-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2025-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-04-012025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/2024-04-012025-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FRS1022024-04-012025-03-31http://www.companieshouse.gov.uk/2025-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-04-012025-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-04-012025-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 10663549

GRENA BIOMED LTD

ACCOUNTS
FOR THE YEAR ENDED 31/03/2025

Prepared By:
Primus Accounting Ltd
Accountancy Services
896
Woodborough Road
Nottingham

GRENA BIOMED LTD

ACCOUNTS
FOR THE YEAR ENDED 31/03/2025
DIRECTORS
KONRAD BRODACZEWSKI
REGISTERED OFFICE
CHELSEA HOUSE
CHELSEA STREET
NOTTINGHAM
NOTTINGHAMSHIRE
NG7 7HP
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 10663549
ACCOUNTANTS
Primus Accounting Ltd
Accountancy Services
896
Woodborough Road
Nottingham

GRENA BIOMED LTD

ACCOUNTS
FOR THEYEARENDED31/03/2025
CONTENTS
Page
Directors' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

GRENA BIOMED LTD

BALANCE SHEET AT 31/03/2025
20252024
Notes££
FIXED ASSETS
Tangible assets3460785
CURRENT ASSETS
Stock287,60764,565
Debtors513,470(84,129)
Cash at bank and in hand288,301282,350
589,378262,786
CREDITORS: Amounts falling due within one year6375,371348,854
NET CURRENT ASSETS / (LIABILITIES)214,007(86,068)
TOTAL ASSETS LESS CURRENT LIABILITIES214,467(85,283)
CAPITAL AND RESERVES
Called up share capital7100100
Profit and loss account214,367(85,383)
SHAREHOLDERS' FUNDS214,467(85,283)
For the year ending 31/03/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 16/12/2025 and signed on their behalf by
.............................
KONRAD BRODACZEWSKI
Director

GRENA BIOMED LTD

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/03/2025
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Equipmentstraight line 25%
1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
1d. Foreign Currency
Transactions in currencies, other than the functional currency of the company, are recorded at the rate of the exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items that are measured at the historic cost in a foreign currency are not retranslated.
2. EMPLOYEES
20252024
No.No.
Average number of employees--

GRENA BIOMED LTD

3. TANGIBLE FIXED ASSETS
EquipmentTotal
££
Cost
At 01/04/20241,2991,299
At 31/03/20251,2991,299
Depreciation
At 01/04/2024514514
For the year325325
At 31/03/2025839839
Net Book Amounts
At 31/03/2025460460
At 31/03/2024785785
4. STOCK 20252024
££
Stock comprises:
Stock287,60764,565
287,60764,565
5. DEBTORS 20252024
££
Amounts falling due within one year
Trade debtors(2,437)(100,243)
VAT15,90716,114
13,470(84,129)
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20252024
££
UK corporation tax56,774-
Directors current account82,57282,572
Trade creditors236,025266,282
375,371348,854

GRENA BIOMED LTD

7. SHARE CAPITAL 20252024
££
Allotted, issued and fully paid:
100 Class 1 shares of £1 each100100
100100